临床营养市场规模、份额和成长分析（按给药途径、分销管道、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，临床营养市场规模将达到 417.6 亿美元，到 2025 年将达到 450.6 亿美元，到 2033 年将达到 827.8 亿美元，预测期（2026-2033 年）的复合年增长率为 7.9%。

临床营养在改善代谢功能方面发挥着至关重要的作用，它提供人体必需的营养素，例如维生素和矿物质，这些营养素对提升健康至关重要。该领域专注于解决影响食物摄取、消化和代谢的各种问题，同时致力于预防与饮食相关的疾病。临床营养在多种场景中都至关重要，包括心臟復健、肾臟护理、糖尿病管理、小儿科、癌症治疗和社区健康计画。文明病的日益增加和人口老化正在推动对临床营养解决方案的需求。此外，政府对医学研究投入的不断增加以及营养产品在居家照护中的广泛应用也进一步促进了市场成长。亚太和拉丁美洲等新兴市场蕴藏着巨大的机会，使临床营养成为一个极具吸引力的投资领域。

临床营养市场驱动因素

社会老化正对临床营养市场的发展产生重大影响。随着老龄化，人们的活动量下降、新陈代谢减慢、能量需求降低，同时营养吸收和利用也面临挑战。这些变化增加了老年人的营养需求，从而推动了对能够改善能量吸收和利用的专用临床营养产品的需求。这些因素对于推动市场成长至关重要，因为老年人在努力维持健康和生活品质的过程中，对个人化营养解决方案的需求日益凸显。

临床营养市场中的阻碍因素

儘管对治疗性营养的需求日益增长，但人们对医疗和饮食实践的认知仍然不足。这种对临床营养益处的理解不足在已开发国家和开发中国家都普遍存在。此外，关于维生素和饮食实践的错误讯息传播加剧了营养缺乏和相关健康问题。因此，临床营养方面存在的巨大知识鸿沟和普遍误解是阻碍临床营养市场成长的主要挑战。这些因素阻碍了潜在的进步，并透过限制临床营养解决方案的更广泛接受和应用，限制了市场扩张。

临床营养市场趋势

临床营养市场正经历显着成长，这主要得益于医疗基础设施的不断完善以及对先进医疗解决方案日益增长的需求，尤其是在亚太和拉丁美洲、中东和非洲（LAMEA）等新兴地区。文明病疾病和慢性病的增加，使得人们更迫切地需要全面的营养支持来应对营养不良和饮食挑战。此外，针对呼吸系统疾病、肾臟疾病和癌症等各种健康状况的医疗设备的持续研发和创新，也进一步推动了市场需求。医疗技术的进步与饮食需求的融合，凸显了向满足不同患者需求的综合性临床营养解决方案发展的强劲趋势。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 监管环境
• 专利分析
• 价值链分析
• PESTEL 分析
• 市场吸引力指数
• 原料分析
• 定价分析

全球临床营养市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

• 口服
• 肠外
• 经肠营养

全球临床营养市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 癌症
• 神经系统疾病
• 消化系统疾病
• 代谢性疾病
• 其他的

全球临床营养市场规模（依分销管道划分）及复合年增长率（2026-2033 年）

• 在线的
• 离线
  • 零售店
  • 机构销售管道
  • 其他的

全球临床营养市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 儿童
• 成人
• 老年人

全球临床营养市场规模（依营养成分划分）及复合年增长率（2026-2033 年）

• 蛋白质营养
• 富含维生素和矿物质的营养
• 以碳水化合物为基础的营养
• 脂质营养

全球临床营养市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Abbott Laboratories（US）
• Nestle Health Science（Switzerland）
• Danone Nutricia（France）
• Fresenius Kabi（Germany）
• Baxter International（US）
• B. Braun Melsungen AG（Germany）
• Mead Johnson Nutrition（Reckitt）（US）
• GlaxoSmithKline（GSK）（UK）
• Pfizer（US）
• Ajinomoto Co., Inc.（Japan）
• Koninklijke DSM NV（Netherlands）
• Lonza Group（Switzerland）
• Cambrooke Therapeutics（US）
• Sichuan Kelun Pharmaceutical Co. Ltd.（China）
• Otsuka Pharmaceutical（Japan）
• Hormel Health Labs（US）
• Perrigo Company（Ireland）
• Hero Group（Switzerland）
• Victus（US）
• Entrocare Nutritional Solutions（UK）

结论与建议

Clinical Nutrition Market size was valued at USD 41.76 Billion in 2024 and is poised to grow from USD 45.06 Billion in 2025 to USD 82.78 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

Clinical nutrition plays a pivotal role in enhancing metabolic function by supplying essential nutrients, such as vitamins and minerals, crucial for improving health outcomes. This field focuses on addressing conditions impacting food intake, digestion, and metabolism, while also working to prevent diet-related diseases. Clinical nutrition is vital in diverse settings, including cardiac rehabilitation, renal care, diabetes management, pediatrics, cancer treatment, and community wellness programs. The escalating prevalence of lifestyle-related diseases and an aging population are driving the demand for clinical nutrition solutions. Additionally, increased government funding in healthcare research and a surge in nutritional product usage for home care further catalyze market growth. Emerging markets in Asia-Pacific and Latin America present significant opportunities, making clinical nutrition an appealing investment landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Nutrition Market Segments Analysis

Global Clinical Nutrition Market is segmented by Route of Administration, application, Distribution Channel, end user, Nutritional Content and region. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Enteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorder, Metabolic Disorder, and Others. Based on Distribution Channel, the market is segmented into Online and Offline. Based on end user, the market is segmented into Paediatric, Adults, and Geriatric. Based on By Nutritional Content, the market is segmented into Protein-Based Nutrition, Vitamin and Mineral-Rich Nutrition, Carbohydrate-Based Nutrition, and Fat-Based Nutrition. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Clinical Nutrition Market

The growing elderly population is significantly influencing the development of the clinical nutrition market. As individuals age, they typically experience reduced activity levels, a decline in metabolic rates, and diminished energy demands, alongside challenges in nutrient absorption and utilization. This decline leads to heightened nutritional requirements among older adults, driving the demand for specialized clinical nutrition products that enhance energy absorption and utilization. Consequently, these factors are essential in fostering market growth, as the need for tailored nutritional solutions becomes increasingly prominent among aging populations seeking to maintain their health and well-being.

Restraints in the Clinical Nutrition Market

Despite a growing demand for therapeutic nutrition, awareness around healthcare and dietary practices remains low. This lack of understanding regarding the benefits of clinical nutrition exists in both developed and developing countries. Additionally, the spread of incorrect information regarding vitamins and dietary practices contributes to deficiencies and related health issues. As a result, the significant gaps in knowledge surrounding clinical nutrition, along with general misconceptions, represent major challenges that inhibit the growth of the clinical nutrition market. These factors hinder potential advancements and limit the market's expansion by preventing broader acceptance and utilization of clinical nutrition solutions.

Market Trends of the Clinical Nutrition Market

The clinical nutrition market is experiencing significant growth, particularly in emerging regions such as Asia-Pacific and LAMEA, driven by enhanced healthcare infrastructure and a rising demand for advanced healthcare solutions. The increasing prevalence of lifestyle-related and chronic diseases is creating urgent needs for comprehensive nutritional support, addressing malnutrition and dietary challenges. Additionally, ongoing research and innovation in medical devices aimed at managing various health conditions, including respiratory, renal, and cancer-related issues, are further propelling market demand. This convergence of healthcare advancements and dietary needs underscores a robust trend toward integrated clinical nutrition solutions tailored to diverse patient requirements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Market Attractiveness Index
• Raw Material Analysis
• Pricing Analysis

Global Clinical Nutrition Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Parenteral
• Enteral

Global Clinical Nutrition Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cancer
• Neurological Diseases
• Gastrointestinal Disorder
• Metabolic Disorder
• Others

Global Clinical Nutrition Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Online
• Offline
  • Retail Stores
  • Institutional Sales Channel
  • Others

Global Clinical Nutrition Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pediatrics
• Adults
• Geriatric

Global Clinical Nutrition Market Size by Nutritional Content & CAGR (2026-2033)

• Market Overview
• Protein-Based Nutrition
• Vitamin and Mineral-Rich Nutrition
• Carbohydrate-Based Nutrition
• Fat-Based Nutrition

Global Clinical Nutrition Market Size & CAGR (2026-2033)

• North America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • US
  • Canada
• Europe, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danone Nutricia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mead Johnson Nutrition (Reckitt) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK) (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Co., Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke DSM N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrooke Therapeutics (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Kelun Pharmaceutical Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hormel Health Labs (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hero Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Victus (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entrocare Nutritional Solutions (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation